Abcellera Biologics Inc. · NASDAQ:ABCL
Abcellera Biologics Inc. shareholders
As of Jun 30, 2026, 150 institutions reported holding Abcellera Biologics Inc., 37.9% of its shares. Largest: Baker Bros. Advisors LP, Capital Group and Two Sigma. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Abcellera Biologics Inc. | Change | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 33M | 10.8% | +2.74M | Aug 14, 2026 |
| Capital Group | 13.6M | 4.4% | +227K | Aug 12, 2026 |
| Two Sigma | 10.4M | 3.4% | −125K | Aug 14, 2026 |
| TD | 9.57M | 3.1% | +3,490 | Jul 27, 2026 |
| UBS | 6.19M | 2.0% | −5.6M | Aug 13, 2026 |
| Bank of America | 6.14M | 2.0% | +3.14M | Aug 14, 2026 |
| ArrowMark Colorado Holdings LLC | 4.11M | 1.3% | held for review | Aug 13, 2026 |
| BlackRock | 3.81M | 1.2% | −235K | Aug 7, 2026 |
| Driehaus Capital Management LLC | 2.86M | 0.93% | −1.16M | Aug 14, 2026 |
| Tudor Investment Corp Et Al | 2.06M | 0.67% | −210K | Aug 14, 2026 |